Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$12.21 USD

12.21
6,647,088

+0.71 (6.17%)

Updated Aug 4, 2025 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (230 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Best Value Stocks to Buy for June 7th

by Zacks Equity Research

LPX, GOGL, and CC made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 7, 2022.

Zacks Equity Research

Is Chemours (CC) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Best Value Stocks to Buy for June 3rd

by Zacks Equity Research

AMR, MBUU, and CC made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 3, 2022.

Zacks Equity Research

Cabot (CBT) Shares Hit 52-week High: What's Driving It?

by Zacks Equity Research

Cabot (CBT) is gaining from a recovery in demand and strategic acquisitions.

Zacks Equity Research

Why Is Chemours (CC) Up 10.7% Since Last Earnings Report?

by Zacks Equity Research

Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Here's Why You Should Invest In Chemours (CC) Stock Now

by Zacks Equity Research

Chemours (CC) is gaining from higher volumes on the back of strong demand, its cost and pricing actions and strong execution.

Zacks Equity Research

Chemours (CC) Evaluates Capacity Investments for Hydrogen Economy

by Zacks Equity Research

Chemours' (CC) higher ionomers capacity would support demand growth within water electrolysis and fuel cell technology.

Zacks Equity Research

Is Chemours (CC) Outperforming Other Basic Materials Stocks This Year?

by Zacks Equity Research

Here is how Chemours (CC) and Gerdau (GGB) have performed compared to their sector so far this year.

Zacks Equity Research

Chemours (CC) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Chemours (CC) Declares New Process for APA Grade Viton Production

by Zacks Equity Research

Chemours (CC) now has the potential to produce the complete Viton fluoroelastomers portfolio using a non-fluorinated surfactant.

Zacks Equity Research

Chemours (CC) Stock Pops 44% in 3 Months: What's Driving It?

by Zacks Equity Research

Chemours (CC) is benefiting from strong end-market demand and its cost-reduction and pricing actions.

Zacks Equity Research

Zacks Industry Outlook Highlights Dow, Albemarle, Huntsman and The Chemours

by Zacks Equity Research

Dow, Albemarle, Huntsman and The Chemours have been highlighted in this Industry Outlook article.

Anindya Barman headshot

4 Stocks to Buy From the Promising Diversified Chemical Industry

by Anindya Barman

An upswing in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. DOW, ALB, HUN and CC are set to gain from favorable industry fundamentals and strategic actions to counter cost inflation.

Zacks Equity Research

Is Chemours (CC) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Zacks.com featured highlights include Imperial Oil, CF Industry Holdings, The Chemours, Medifast, and APA

by Zacks Equity Research

Imperial Oil, CF Industry Holdings, The Chemours, Medifast, and APA are part of Screen of the Week article.

Rimmi Singhi headshot

5 High Earnings Yield Value Picks Amid Market Jitters

by Rimmi Singhi

Value investing should be one of the most effective investment approaches now. IMO, CF, CC, MED and APA are some high earnings yield value stocks to tide over market mayhem.

Zacks Equity Research

The Zacks Analyst Blog Highlights Penske Automotive Group, Griffon, Louisiana-Pacific, The Chemours, and Avnet

by Zacks Equity Research

Penske Automotive Group, Griffon, Louisiana-Pacific, The Chemours, and Avnet are part of Zacks top Analyst Blog.

Zacks Equity Research

Is Chemours (CC) a Great Stock for Value Investors?

by Zacks Equity Research

Is Chemours (CC) a great pick from the value investor's perspective right now? Read on to know more.

Nalak Das headshot

5 Must-Buy Mid Cap Winners of Past Month With More Upside

by Nalak Das

We have narrowed our search to five mid-cap stocks that have popped double-digit in the past month, with more upside. These are: LPX, GFF, PAG, CC and AVT.

Zacks Equity Research

Should You Buy Chemours (CC) After Golden Cross?

by Zacks Equity Research

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

Zacks Equity Research

Are Basic Materials Stocks Lagging Carpenter Technology (CRS) This Year?

by Zacks Equity Research

Here is how Carpenter Technology (CRS) and Chemours (CC) have performed compared to their sector so far this year.

Zacks Equity Research

Chemours (CC) Shows Fast-paced Momentum But Is Still a Bargain Stock

by Zacks Equity Research

Chemours (CC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Equity Research

Chemours (CC) Earnings and Revenues Top Estimates in Q1

by Zacks Equity Research

Chemours (CC) gains on strong volumes and higher prices amid headwinds from raw material cost inflation and logistics challenges in Q1.

Zacks Equity Research

Chemours (CC) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Chemours (CC) delivered earnings and revenue surprises of 58.70% and 14.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Scotts Miracle-Gro (SMG) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

ScottsMiracle-Gro's (SMG) Q2 performance is likely to have benefited from strength in the U.S. Consumer segment and cost savings.